Skip to main content Accessibility help

Neural correlates of improved executive function following erythropoietin treatment in mood disorders

  • K. W. Miskowiak (a1) (a2), M. Vinberg (a1), L. Glerup (a1), O. B. Paulson (a2) (a3) (a4), G. M. Knudsen (a3) (a4), H. Ehrenreich (a5), C. J. Harmer (a6), L. V. Kessing (a1), H. R. Siebner (a2) (a3) (a7) and J. Macoveanu (a1) (a2) (a3)...



Cognitive dysfunction in depression and bipolar disorder (BD) is insufficiently targeted by available treatments. Erythropoietin (EPO) increases neuroplasticity and may improve cognition in mood disorders, but the neuronal mechanisms of these effects are unknown. This functional magnetic resonance imaging (fMRI) study investigated the effects of EPO on neural circuitry activity during working memory (WM) performance.


Patients with treatment-resistant major depression, who were moderately depressed, or with BD in partial remission, were randomized to eight weekly infusions of EPO (40 000 IU) (N = 30) or saline (N = 26) in a double-blind, parallel-group design. Patients underwent fMRI, mood ratings and blood tests at baseline and week 14. During fMRI patients performed an n-back WM task.


EPO improved WM accuracy compared with saline (p = 0.045). Whole-brain analyses revealed that EPO increased WM load-related activity in the right superior frontal gyrus (SFG) compared with saline (p = 0.01). There was also enhanced WM load-related deactivation of the left hippocampus in EPO-treated compared to saline-treated patients (p = 0.03). Across the entire sample, baseline to follow-up changes in WM performance correlated positively with changes in WM-related SFG activity and negatively with hippocampal response (r = 0.28–0.30, p < 0.05). The effects of EPO were not associated with changes in mood or red blood cells (p ⩾0.08).


The present findings associate changes in WM-load related activity in the right SFG and left hippocampus with improved executive function in EPO-treated patients. Clinical trial registration: NCT00916552.


Corresponding author

*Address for correspondence: Dr K. W. Miskowiak, Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. (Email:


Hide All
Bora, E, Harrison, BJ, Yucel, M, Pantelis, C (2013). Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychological Medicine 43, 20172026.
Bourne, C, Aydemir, O, Balanza-Martinez, V, Bora, E, Brissos, S, Cavanagh, JT, Clark, L, Cubukcuoglu, Z, Dias, VV, Dittmann, S, Ferrier, IN, Fleck, DE, Frangou, S, Gallagher, P, Jones, L, Kieseppa, T, Martinez-Aran, A, Melle, I, Moore, PB, Mur, M, Pfennig, A, Raust, A, Senturk, V, Simonsen, C, Smith, DJ, Bio, DS, Soeiro-de-Souza, MG, Stoddart, SD, Sundet, K, Szoke, A, Thompson, JM, Torrent, C, Zalla, T, Craddock, N, Andreassen, OA, Leboyer, M, Vieta, E, Bauer, M, Worhunsky, PD, Tzagarakis, C, Rogers, RD, Geddes, JR, Goodwin, GM (2013). Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatrica Scandinavica 128, 149162.
Brines, ML, Ghezzi, P, Keenan, S, Agnello, D, de Lanerolle, NC, Cerami, C, Itri, LM, Cerami, A (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proceedings of the National Academy of Sciences USA 97, 1052610531.
Callicott, JH, Mattay, VS, Bertolino, A, Finn, K, Coppola, R, Frank, JA, Goldberg, TE, Weinberger, DR (1999). Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cerebral Cortex 9, 2026.
Carlson, PJ, Singh, JB, Zarate, CA Jr., Drevets, WC, Manji, HK (2006). Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 3, 2241.
Demant, KM, Almer, GM, Vinberg, M, Kessing, LV, Miskowiak, KW (2013). Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial. Trials 14, 378.
Demant, KM, Vinberg, M, Kessing, LV, Miskowiak, KW (2015). Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial. PLoS ONE 10, e0127955.
Depp, CA, Mausbach, BT, Harmell, AL, Savla, GN, Bowie, CR, Harvey, PD, Patterson, TL (2012). Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disorder 14, 217226.
Dias, VV, Balanza-Martinez, V, Soeiro-de-Souza, MG, Moreno, RA, Figueira, ML, Machado-Vieira, R, Vieta, E (2012). Pharmacological approaches in bipolar disorder and the impact on cognition: a critical overview. Acta Psychiatrica Scandinavica 126, 315331.
Ehrenreich, H, Degner, D, Meller, J, Brines, M, Béhé, M, Hasselblatt, M, Woldt, H, Falkai, P, Knerlich, F, Jacob, S, von Ahsen, N, Maier, W, Brück, W, Rüther, E, Cerami, A, Becker, W, Sirén, AL (2004). Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Molecular Psychiatry 9, 4254.
Ehrenreich, H, Fischer, B, Norra, C, Schellenberger, F, Stender, N, Stiefel, M, Siren, AL, Paulus, W, Nave, KA, Gold, R, Bartels, C (2007 a). Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130, 25772588.
Ehrenreich, H, Hinze-Selch, D, Stawicki, S, Aust, C, Knolle-Veentjer, S, Wilms, S, Heinz, G, Erdag, S, Jahn, H, Degner, D, Ritzen, M, Mohr, A, Wagner, M, Schneider, U, Bohn, M, Huber, M, Czernik, A, Pollmacher, T, Maier, W, Siren, AL, Klosterkotter, J, Falkai, P, Ruther, E, Aldenhoff, JB, Krampe, H (2007 b). Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Molecular Psychiatry 12, 206220.
Fernandez-Corcuera, P, Salvador, R, Monte, GC, Salvador, SS, Goikolea, JM, Amann, B, Moro, N, Sans-Sansa, B, Ortiz-Gil, J, Vieta, E, Maristany, T, McKenna, PJ, Pomarol-Clotet, E (2013). Bipolar depressed patients show both failure to activate and failure to de-activate during performance of a working memory task. Journal of Affective Disorder 148, 170178.
Filippi, M, Riccitelli, G, Mattioli, F, Capra, R, Stampatori, C, Pagani, E, Valsasina, P, Copetti, M, Falini, A, Comi, G, Rocca, MA (2012). Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures–-an explorative study. Radiology 262, 932940.
Garrett, A, Kelly, R, Gomez, R, Keller, J, Schatzberg, AF, Reiss, AL (2011). Aberrant brain activation during a working memory task in psychotic major depression. American Journal of Psychiatry 168, 173182.
Ge, XH, Zhu, GJ, Geng, DQ, Zhang, ZJ, Liu, CF (2012). Erythropoietin attenuates 6-hydroxydopamine-induced apoptosis via glycogen synthase kinase 3beta-mediated mitochondrial translocation of Bax in PC12 cells. Neurological Sciences 33, 12491256.
Gonzalez-Castillo, J, Roopchansingh, V, Bandettini, PA, Bodurka, J (2011). Physiological noise effects on the flip angle selection in BOLD fMRI. Neuroimage 54, 27642778.
Grier, JB (1971). Nonparametric indices for sensitivity and bias: computing formulas. Psychological Bulletin 75, 424429.
Harvey, PO, Fossati, P, Pochon, JB, Levy, R, Lebastard, G, Lehericy, S, Allilaire, JF, Dubois, B (2005). Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroimage 26, 860869.
Jaeger, J, Berns, S, Uzelac, S, Davis-Conway, S (2006). Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research 145, 3948.
Kastner, A, Grube, S, El-Kordi, A, Stepniak, B, Friedrichs, H, Sargin, D, Schwitulla, J, Begemann, M, Giegling, I, Miskowiak, KW, Sperling, S, Hannke, K, Ramin, A, Heinrich, R, Gefeller, O, Nave, KA, Rujescu, D, Ehrenreich, H (2012). Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Molecular Medicine 18, 10291040.
Maldjian, JA, Laurienti, PJ, Kraft, RA, Burdette, JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19, 12331239.
Marsden, WN (2013). Synaptic plasticity in depression: molecular, cellular and functional correlates. Progress in Neuropsychopharmacology and Biological Psychiatry 43, 168184.
Matsuo, K, Glahn, DC, Peluso, MA, Hatch, JP, Monkul, ES, Najt, P, Sanches, M, Zamarripa, F, Li, J, Lancaster, JL, Fox, PT, Gao, JH, Soares, JC (2007). Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder. Molecular Psychiatry 12, 158166.
McDonald, JH (2014). Handbook of Biological Statistics. Sparky House Publishing: Baltimore, Maryland.
Meusel, LA, Hall, GB, Fougere, P, McKinnon, MC, MacQueen, GM (2013). Neural correlates of cognitive remediation in patients with mood disorders. Psychiatry Research 214, 142152.
Miskowiak, K, Inkster, B, O'Sullivan, U, Selvaraj, S, Goodwin, GM, Harmer, CJ (2008). Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration. Experimental Brain Research 184, 313321.
Miskowiak, K, O'Sullivan, U, Harmer, CJ (2007). Erythropoietin enhances hippocampal response during memory retrieval in humans. Journal of Neuroscience 27, 27882792.
Miskowiak, KW, Ehrenreich, H, Christensen, EM, Kessing, LV, Vinberg, M (2014 a). Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. Journal of Clinical Psychiatry 75, 13471355.
Miskowiak, KW, Favaron, E, Hafizi, S, Inkster, B, Goodwin, GM, Cowen, PJ, Harmer, CJ (2009). Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology (Berlin) 207, 133142.
Miskowiak, KW, Glerup, L, Vestbo, C, Harmer, CJ, Reinecke, A, Macoveanu, J, Siebner, HR, Kessing, LV, Vinberg, M (2014 b). Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression. Psychological Medicine 45, 14471458.
Miskowiak, KW, Vinberg, M, Christensen, EM, Bukh, JD, Harmer, CJ, Ehrenreich, H, Kessing, LV (2014 c). Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology 39, 13991408.
Miskowiak, KW, Vinberg, M, Harmer, CJ, Ehrenreich, H, Kessing, LV (2012). Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berlin) 219, 687698.
Miskowiak, KW, Vinberg, M, Harmer, CJ, Ehrenreich, H, Knudsen, GM, Macoveanu, J, Hansen, AR, Paulson, OB, Siebner, HR, Kessing, LV (2010). Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials 11, 97.
Miskowiak, KW, Vinberg, M, Macoveanu, J, Ehrenreich, H, Koster, N, Inkster, B, Paulson, OB, Kessing, LV, Skimminge, A, Siebner, HR (2015). Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders. Biological Psychiatry 78, 270277.
Nathan, PJ, Phan, KL, Harmer, CJ, Mehta, MA, Bullmore, ET (2014). Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery. Current Opinion in Pharmacology 14, 5461.
Pomarol-Clotet, E, Alonso-Lana, S, Moro, N, Sarro, S, Bonnin, MC, Goikolea, JM, Fernandez-Corcuera, P, Amann, BL, Romaguera, A, Vieta, E, Blanch, J, McKenna, PJ, Salvador, R (2015). Brain functional changes across the different phases of Bipolar disorder . British Journal of Psychiatry 206, 136144.
Porter, RJ, Bowie, CR, Jordan, J, Malhi, GS (2013). Cognitive remediation as a treatment for major depression: a rationale, review of evidence and recommendations for future research. Australian and New Zealand Journal of Psychiatry 47, 11651175.
Raichle, ME, MacLeod, AM, Snyder, AZ, Powers, WJ, Gusnard, DA, Shulman, GL (2001). A default mode of brain function. Proceedings of the National Academy of Sciences 98, 676682.
Ramsay, IS, MacDonald, AW III (2015). Brain correlates of cognitive remediation in Schizophrenia: activation likelihood analysis shows preliminary evidence of neural target engagement. Schizophrenia Bulletin 41, 12761284.
Sheline, YI, Barch, DM, Price, JL, Rundle, MM, Vaishnavi, SN, Snyder, AZ, Mintun, MA, Wang, S, Coalson, RS, Raichle, ME (2009). The default mode network and self-referential processes in depression. Proceedings of the National Academy of Sciences USA 106, 19421947.
Siegle, GJ, Thompson, W, Carter, CS, Steinhauer, SR, Thase, ME (2007). Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biological Psychiatry 61, 198209.
Siren, AL, Fasshauer, T, Bartels, C, Ehrenreich, H (2009). Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6, 108127.
Subramaniam, K, Luks, TL, Garrett, C, Chung, C, Fisher, M, Nagarajan, S, Vinogradov, S (2014). Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains. Neuroimage 99, 281292.
Talairach, J, Tournoux, P (1988). Co-planar Stereotaxic Atlas of the Human Brain. Thieme: New York.
Townsend, J, Bookheimer, SY, Foland-Ross, LC, Sugar, CA, Altshuler, LL (2010). fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects. Psychiatry Research 182, 2229.
Wager, TD, Smith, EE (2003). Neuroimaging studies of working memory: a meta-analysis. Cognive, Affective and Behavioral Neuroscience 3, 255274.
Wang, R, Foniok, T, Wamsteeker, JI, Qiao, M, Tomanek, B, Vivanco, RA, Tuor, UI (2006). Transient blood pressure changes affect the functional magnetic resonance imaging detection of cerebral activation. Neuroimage 31, 111.
Woolrich, MW, Behrens, TE, Beckmann, CF, Jenkinson, M, Smith, SM (2004). Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage 21, 17321747.
Worsley, KJ (2001). In Functional MRI: An Introduction to Methods (ed. Jezzars, P. M., Matthews, P. and Smith, S. M.) pp. 251270. Oxford University Press: Oxford.
Zandbelt, BB, Gladwin, TE, Raemaekers, M, van, BM, Neggers, SF, Kahn, RS, Ramsey, NF, Vink, M (2008). Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage 42, 196206.


Type Description Title
Supplementary materials

Miskowiak supplementary material
Miskowiak supplementary material 1

 Unknown (123 KB)
123 KB
Supplementary materials

Miskowiak supplementary material
Miskowiak supplementary material 2

 Unknown (83 KB)
83 KB
Supplementary materials

Miskowiak supplementary material
Miskowiak supplementary material 3

 Word (12 KB)
12 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed